Iscador Qu Viscum Album Extract
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iscador Qu Viscum Album Extract, covering 2024-12-27 to 2024-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors [Phase 4]